(Q87409543)
Statements
Lipid modification and cardiovascular risk assessment for the primary and secondary prevention of cardiovascular disease: summary of updated NICE guidance (English)
Guideline Development Group
Silvia Rabar
Martin Harker
Norma O'Flynn
Anthony S Wierzbicki